Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model

Sheila Alcantara Llaguno1, Jian Chen, Chang-Hyuk Kwon

  • 1Department of Developmental Biology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.

Cancer Cell
|December 30, 2008
PubMed

Insights

Malignant astrocytomas originate from neural stem/progenitor cells. Inactivating tumor suppressors (p53, Nf1, Pten) in these cells is necessary and sufficient for astrocytoma development, revealing a pretumorigenic cell population.

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Stem Cell Biology

Background:

  • Malignant astrocytomas are aggressive brain tumors with unknown cell of origin.
  • Identifying the cell of origin is crucial for developing effective therapies.

Purpose of the Study:

  • To determine the cell of origin for malignant astrocytomas.
  • To investigate the role of neural stem/progenitor cells in astrocytoma formation.

Main Methods:

  • Utilized genetically engineered mouse models with conditional inactivation of p53, Nf1, and Pten tumor suppressors.
  • Analyzed tumor development and cell behavior in vivo and in vitro using neural stem/progenitor cell cultures.

Main Results:

  • Tumor suppressor inactivation in neural stem/progenitor cells was sufficient to induce astrocytoma formation.
  • Transformed cells infiltrated tissues and exhibited multilineage differentiation during tumorigenesis.
  • Presymptomatic neural stem/progenitor cell cultures showed aberrant growth and altered differentiation, indicating a pretumorigenic state.

Conclusions:

  • Neural stem/progenitor cells are the cell of origin for malignant astrocytomas.
  • Early genetic alterations in these cells lead to aberrant growth and differentiation, initiating tumor development.